Economic evaluation of different sampling strategies for cervical cancer screening
Our recently published paper comparing different cervical screening options in England provides early economic evidence that sample self-collection may be a cost-effective option for cervical cancer screening programmes. This work supports decision-making for cervical screening programmes. Cervical cancer is the fourth most common cancer among women worldwide, yet most cases are preventable through early detection Read More >
Aquarius part of collaborative NIHR grant to evaluate Odin Vision’s artificial intelligence technology to fight bowel cancer
In the UK, 42,000 new diagnoses and 16,000 deaths occur from bowel cancer each year. Bowel cancer is the second most common cause of cancer death in the UK, comprising over 10% of all deaths due to cancer. (1) A recent study found that almost one third of bowel cancer patients experience an avoidable delay Read More >
Aquarius supports the Royal Marsden as they assess an innovative device for breast cancer surgery
In the latest episode of the BBC’s show, “Trust me, I’m a Doctor”, an innovative new product called Magseed is being trialled to improve surgery for women with breast cancer. A tiny magnetic seed is being used to transform how cancerous tissue is localised so that it can be removed, rather than using traditional guide Read More >
Aquarius Population Health presents the breast cancer diagnostic pathway at ISPOR Milan
Dr Elisabeth Adams, will present “Mapping the diagnostic pathway for breast cancer in England and comparison to Europe” at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Milan 7 – 11 November, 2015. Read More >
Rapid on-demand testing of HPV and cervical cancer prevention: IPV Conference in Lisbon
Aquarius Population Health will be presenting European screening programmes outcomes and opportunities for rapid HPV testing in the UK at the 2015 HPV conference in Lisbon. http://www.hpv2015.org Read More >